Medicine pack check sheet

Source-linked reading points

• The boxed warning states that sotalol can cause life-threatening ventricular tachycardia associated with QT prolongation. Initiation or reinitiation requires a facility with continuous ECG monitoring and cardiac resuscitation, with dosing interval based on creatinine clearance. The site cannot turn these professional monitoring requirements into a home adjustment table.
• Bradycardia, atrioventricular block, hypotension, heart failure, dizziness or syncope can increase fall and acute risk. Severe fainting, symptomatic palpitations, chest pain, breathing difficulty, seizure or altered awareness needs local emergency care; do not wait for a webpage to decide.
• Severe diarrhoea, vomiting, unusual sweating, markedly reduced appetite or excessive thirst can change electrolytes such as potassium and magnesium and affect proarrhythmic risk. Older adults, changing kidney function or co-use of a diuretic needs timely clinical review, not self-supplementation, stopping or catch-up dosing.
• The label says to avoid self-co-use with Class I or III antiarrhythmics and other QT-prolonging medicines. Digoxin, verapamil/diltiazem, another beta blocker or clonidine can further affect heart rate, pressure or cardiac function. Do not self-space, alternate or choose one to stop when these names appear together.